Development of candidates for new type 2 and type 3 oral poliovirus vaccines
- PMID: 8388824
Development of candidates for new type 2 and type 3 oral poliovirus vaccines
Abstract
Monkey neurovirulence tests on in vitro recombinant viruses between the virulent Mahoney and the attenuated Sabin 1 strains of type 1 poliovirus revealed that a strong neurovirulence determinant(s) resided in the 5' non-coding sequence of the genome and that the surface structure of the virion particle had a little correlation with the neurovirulence or attenuation phenotype. The results suggested that new and safer vaccine strains of type 2 and type 3 polioviruses may be constructed in vitro by replacing the sequence encoding the antigenic determinants in viral capsid proteins of the Sabin 1 genome by the corresponding sequences of the type 2 and type 3 genome, respectively, because the Sabin 1 strain is the safest vaccine among the Sabin strains. We have constructed recombinant viruses, PV1/2 (SS)BB and PV1/3(SS)BN, as vaccine candidates for type 2 and type 3 oral poliovirus vaccines respectively. These recombinant viruses were fully viable and showed antigenicities and immunogenicities identical to those of type 2 and type 3 polioviruses respectively. The monkey neurovirulence tests performed on these recombinant viruses suggest that the recombinant viruses are possible candidates for new type 2 and type 3 poliovirus vaccine strains.
Similar articles
-
Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.Virology. 1999 May 25;258(1):152-60. doi: 10.1006/viro.1999.9718. Virology. 1999. PMID: 10329577
-
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.J Virol. 1988 Aug;62(8):2828-35. doi: 10.1128/JVI.62.8.2828-2835.1988. J Virol. 1988. PMID: 2839704 Free PMC article.
-
Attenuation and reversion of the Sabin vaccine strains of poliovirus.Dev Biol Stand. 1993;78:17-26. Dev Biol Stand. 1993. PMID: 8388828 Review.
-
Strategy for construction of live picornavirus vaccines.Vaccine. 1988 Apr;6(2):134-7. doi: 10.1016/s0264-410x(88)80015-x. Vaccine. 1988. PMID: 2838985 Review.
-
Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.Dev Biol Stand. 1993;78:93-9; discussion 99-100. Dev Biol Stand. 1993. PMID: 8388835
Cited by
-
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.J Virol. 2006 Sep;80(17):8653-63. doi: 10.1128/JVI.00370-06. J Virol. 2006. PMID: 16912313 Free PMC article.